10.1208/s12248-017-0096-2 AAPS J
Despite these underwhelming results, Novo considered the results to be promising and still expects to submit the drug for regulatory approval towards the end of 2025
The patients knew what they were receiving, and the outcomes were self-reported
Post-Gastrointestinal Surgery Patients: If youve undergone surgeries such as gastrectomy or weight loss surgery, we can help monitor and address any potential nutrient deficiencies, including B12
37,38 Patients with metabolic or endocrine conditions such as diabetes mellitus, parathyroid disease, and chronic kidney disease were excluded by 70% of trials
Because the peptide occurs naturally in human plasma (at roughly 200 ng/mL in young adults, declining to approximately 80 ng/mL by age 60), topical supplementation essentially restores youthful local concentrations in treated skin